Stock Track | Moderna Plummets 6.26% as International Revenue Disappoints

Stock Track

Feb 25, 2025

Moderna, Inc. (MRNA) stock plummeted 6.26% on Monday during intraday trading, following the company's disappointing international revenue performance in the fourth quarter of 2024.

The biotechnology company reported total revenue of $966 million for the quarter, marking a significant 65.6% decline from the prior-year period. While Moderna's revenue from Europe exceeded expectations, contributing $292 million (30.23% of total revenue), its performance in the rest of world markets fell short of analysts' projections.

Revenue from the rest of world region totaled $397 million (41.10% of total revenue), missing Wall Street estimates by 27.97%. This lackluster performance, coupled with analysts' projections of further revenue declines in 2025, likely contributed to Moderna's stock plunge.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1127564637"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1127564637\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1127564637?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-25 00:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1127564637","market":"hk","top_or_hot":-1,"title":"Stock Track | Moderna Plummets 6.26% as International Revenue Disappoints","media":"Stock Track","content":"<p>Moderna, Inc. (MRNA) stock plummeted 6.26% on Monday during intraday trading, following the company's disappointing international revenue performance in the fourth quarter of 2024.</p>\n\n<p>The biotechnology company reported total revenue of $966 million for the quarter, marking a significant 65.6% decline from the prior-year period. While Moderna's revenue from Europe exceeded expectations, contributing $292 million (30.23% of total revenue), its performance in the rest of world markets fell short of analysts' projections.</p>\n\n<p>Revenue from the rest of world region totaled $397 million (41.10% of total revenue), missing Wall Street estimates by 27.97%. This lackluster performance, coupled with analysts' projections of further revenue declines in 2025, likely contributed to Moderna's stock plunge.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Moderna Plummets 6.26% as International Revenue Disappoints</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Moderna Plummets 6.26% as International Revenue Disappoints\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-25 00:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna, Inc. (MRNA) stock plummeted 6.26% on Monday during intraday trading, following the company's disappointing international revenue performance in the fourth quarter of 2024.</p>\n\n<p>The biotechnology company reported total revenue of $966 million for the quarter, marking a significant 65.6% decline from the prior-year period. While Moderna's revenue from Europe exceeded expectations, contributing $292 million (30.23% of total revenue), its performance in the rest of world markets fell short of analysts' projections.</p>\n\n<p>Revenue from the rest of world region totaled $397 million (41.10% of total revenue), missing Wall Street estimates by 27.97%. This lackluster performance, coupled with analysts' projections of further revenue declines in 2025, likely contributed to Moderna's stock plunge.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"","article_id":"1127564637","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1127564637","pubTimestamp":1740414388,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Moderna, Inc.  stock plummeted 6.26% on Monday during intraday trading, following the company's disappointing international revenue performance in the fourth quarter of 2024.The biotechnology company reported total revenue of $966 million for the quarter, marking a significant 65.6% decline from the prior-year period. While Moderna's revenue from Europe exceeded expectations, contributing $292 million , its performance in the rest of world markets fell short of analysts' projections.Revenue from","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"由于国际收入令人失望，Moderna股价暴跌6.26%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":1},"content_text":"Moderna, Inc. (MRNA) stock plummeted 6.26% on Monday during intraday trading, following the company's disappointing international revenue performance in the fourth quarter of 2024.\nThe biotechnology company reported total revenue of $966 million for the quarter, marking a significant 65.6% decline from the prior-year period. While Moderna's revenue from Europe exceeded expectations, contributing $292 million (30.23% of total revenue), its performance in the rest of world markets fell short of analysts' projections.\nRevenue from the rest of world region totaled $397 million (41.10% of total revenue), missing Wall Street estimates by 27.97%. This lackluster performance, coupled with analysts' projections of further revenue declines in 2025, likely contributed to Moderna's stock plunge.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}